LH vs PGNY Stock Comparison

Compare LH and PGNY across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.

Market data as of Sep 11, 2026 market close· AIQ score gap 13 points
LH
Healthcare
vs
PGNY
Healthcare
LH
Labcorp Holdings Inc.
Price
$312
Day move
+1.49%
AIQ Score
44/100
Best edge
Value
Sector
Healthcare
PGNY
Progyny, Inc.
Leads
Price
$27.35
Day move
+1%
AIQ Score
57/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between LH and PGNY?

PGNY leads the current stock comparison as Progyny, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Labcorp Holdings Inc. vs Progyny, Inc.

Data as of Sep 11, 2026· market close· Healthcare· Coverage 66/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 7/10

PGNY leads

PGNY leads by 13 AIQ points, primarily on Momentum and Quality, having only recently taken the lead back from LH.

Competitive: 4 of 6 evidence groups support PGNY, the lead recently changed hands, and its signal state is cleanly positive.

Evidence agreement: 4 of 6Comparison trend: Reversed
LH

Labcorp Holdings Inc.

AIQ Score
44/100
AIQ Edge Score
3/10
PGNY

Progyny, Inc.

Leads
AIQ Score
57/100
AIQ Edge Score
9/10

The Algovestiq AIQ Score currently favors PGNY over LH, 57 versus 44 as of Sep 11, 2026. PGNY's advantage is driven primarily by stronger momentum and quality, while LH holds the stronger value profile. PGNY also shows the weaker technical structure relative to its 50-day moving average. 4 of 6 covered evidence groups favor PGNY today, and the comparison is rated Competitive on stability: the lead has already changed hands inside the comparison window. PGNY lead: Reversed — LH led by 7 AIQ points 30 sessions ago; PGNY now leads by 13.

Compare Labcorp Holdings Inc. and Progyny, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price-return comparison using available daily close history.

LH
+20.1%
PGNY
-53.1%

Total return comparison

Growth of $10,000

LH $12,012 · PGNY $4,688

Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.

Compare LH and PGNY against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

LH advantage
0
PGNY advantage
  • Momentum18 vs 58
    PGNY +40
  • Quality42 vs 56
    PGNY +14
  • Value59 vs 51
    LH +8
  • Risk Resilience64 vs 70
    PGNY +6

4 of 6 evidence groups favor PGNY. PGNY’s edge is concentrated in momentum and quality; LH keeps a meaningful value edge.

What changed since the last close

Latest scored session 2026-09-10, compared against the prior scored session 2026-09-09.

LH-7 AIQ

Largest factor move: Momentum -23

New signals

  • BB Lower Band Breach bullish, volatility, short horizon
  • Keltner Channel Breakdown bearish, volatility, short horizon
  • RSI Oversold - Potential Bounce bullish, momentum, short horizon
PGNY-1 AIQ

Largest factor move: Momentum -3

No new signals fired.

PGNY's lead widened by 6 AIQ points in the latest snapshot.

Deeper signal detail for each name lives on its own signals page — LH and PGNY both carry a full feed there.

The central trade-off

PGNY (Progyny, Inc.): the stronger current systematic profile, led by momentum and quality.

LH (Labcorp Holdings Inc.): the counter-case, on value, valuation, technicals.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

PGNY

PGNY on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

PGNY

PGNY on combined revenue and EPS growth.

Value

LH

LH on the peer-relative Value factor, by 8 points.

Momentum

PGNY

PGNY on the Momentum factor, by 40 points.

Lower downside

PGNY

PGNY on Risk Resilience, by 6 points.

Analyst upside

PGNY

PGNY on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureLHPGNYNote
Implied upside to target+5.7%+25.6%PGNY has more room
Target dispersion+16.7%+37.8%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering67Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 6 covered evidence groups favor PGNY. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScorePGNY44 vs 57
FundamentalsPGNYon balancerevenue growth 5.5% vs 6.7%; EPS growth 8.6% vs 20%; TTM ROE 11.6% vs 16%; gross margin 27.8% vs 24.6%; operating margin 11.3% vs 8.6% — PGNY takes 3 of 5 decided legs, not all of them
ValuationLHValue 59 vs 51
TechnicalsLHPrice vs 50-day 0.8% vs -5.1%; vs 200-day 11% vs 12.2%
Risk ResiliencePGNYRisk Resilience 64 vs 70
Analyst expectationsPGNYTarget upside 5.7% vs 25.6%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of LH and PGNY and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 13 points. (supports the conclusion holding)
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The leader's signal state is cleanly positive. (supports the conclusion holding)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on PGNY.

How the comparison changed

119 daily snapshots · May 4 Sep 10

PGNY lead: Reversed — LH led by 7 AIQ points 30 sessions ago; PGNY now leads by 13.

May 4LH leads above the line · PGNY leads belowSep 10
Today
PGNY +13
44 vs 57
7 sessions ago
PGNY +1
55 vs 56
30 sessions ago
LH +7
58 vs 51
90 sessions ago
PGNY +3
62 vs 65

The lead changed hands 4 times in this window, most recently on Sep 4 when PGNY moved ahead of LH.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

LHConflicted

4 bullish / 2 bearish, conflicted

  • Golden Cross Active bullish, trend, long horizon (11.77%)
  • BB Lower Band Breach bullish, volatility, short horizon
  • Keltner Channel Breakdown bearish, volatility, short horizon
PGNY

2 bullish / 0 bearish / 1 neutral

  • Golden Cross Active bullish, trend, long horizon (19.42%)
  • Bollinger Band Squeeze neutral, volatility, short horizon
  • MACD Bullish Crossover bullish, momentum, short horizon

LH is conflicted, so the timing case there is weaker than the score alone suggests.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

LHDivergence

Price is up while the AIQ Score moved down 7 points over the same session — price and model disagree (price +1.49%, AIQ -7 points).

PGNYDivergence

Price is up while the AIQ Score moved down 1 points over the same session — price and model disagree (price +1%, AIQ -1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1LH closes the Momentum gap — currently 40 points behind, the largest single contributor to PGNY's edge.
  2. 2LH's Keltner Channel Breakdown resolves — a bearish volatility rule currently active against it.
  3. 3PGNY's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
  4. 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

PGNY leads on balance
MetricLHPGNY
Revenue growth (YoY)5.5%6.7%
EPS growth (YoY)8.6%20%
Gross margin27.8%24.6%
Operating margin11.3%8.6%
Return on equity (TTM)11.6%16%
Debt to equity0.790.06

Performance

PGNY leads 4 of 6 windows
MetricLHPGNY
1 week (5 sessions)-7.4%3%
1 month (20 sessions)-5.1%6.5%
3 months (63 sessions)14.3%4.6%
6 months (126 sessions)13.5%51.1%
Year to date22.4%5.5%
1 year (252 sessions)10.7%18.5%

Technicals

LH has the stronger structure
MetricLHPGNY
RSI (14)23.560.3
ADX (14)23.835.9
Price vs 50-day0.8%-5.1%
Price vs 200-day11%12.2%
Volatility (1M, annualized)23.3%31.1%

Risk

PGNY is the more resilient
MetricLHPGNY
Beta0.260.37
Sharpe ratio0.370.5
Sortino ratio0.530.71
Max drawdown-15.2%-42.6%
Current drawdown-9.5%-16.3%
Annualized volatility24.1%55.3%
Value at risk (95%)-2.1%-4%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, LH or PGNY?

On the Algovestiq AIQ Score, PGNY is the stronger of the two as of Sep 11, 2026, scoring 57 against LH's 44. The edge comes from momentum and quality. LH is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is LH or PGNY the better buy right now?

PGNY carries the stronger systematic profile as of Sep 11, 2026, and the comparison is rated Competitive — 4 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor PGNY over LH?

The composite weights Quality, Value, Momentum and Risk Resilience. PGNY leads Momentum by 40 points; PGNY leads Quality by 14 points; LH leads Value by 8 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, LH or PGNY?

Analyst price targets imply +5.7% upside for LH and +25.6% for PGNY, so the Street currently favors PGNY. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, LH or PGNY?

LH is the better-valued of the two on the peer-relative Value factor. LH on the peer-relative Value factor, by 8 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, LH or PGNY?

PGNY on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, LH or PGNY?

PGNY on the Momentum factor, by 40 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, LH or PGNY?

PGNY is the more resilient of the two, so the other name carries the higher downside risk. PGNY on Risk Resilience, by 6 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is LH more profitable than PGNY?

The profitability evidence is mixed: gross margin 27.8% vs 24.6%; operating margin 11.3% vs 8.6%; ttm roe 11.6% vs 16%. LH leads on two measures and PGNY on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is PGNY's lead over LH getting stronger or weaker?

PGNY lead: Reversed — LH led by 7 AIQ points 30 sessions ago; PGNY now leads by 13. This is measured from 119 daily comparison snapshots between 2026-05-04 and 2026-09-10. The lead has changed hands 4 times in that window, most recently on 2026-09-04, when PGNY moved ahead of LH.

What would change the LH vs PGNY verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: LH closes the Momentum gap — currently 40 points behind, the largest single contributor to PGNY's edge; LH's Keltner Channel Breakdown resolves — a bearish volatility rule currently active against it; PGNY's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.

What do the current signals say about LH and PGNY?

LH: 4 bullish / 2 bearish, conflicted. PGNY: 2 bullish / 0 bearish / 1 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on LH is Golden Cross Active (bullish, long horizon). On PGNY it is Golden Cross Active (bullish, long horizon).

Compare LH and PGNY with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.